Focused ultrasound puts real energy into living tissue, and the same list is read aloud before consent on either platform. In the first days: redness, swelling, bruising and skin that is sore to the touch. Less commonly: raised welts tracking along a treated line, patches of temporary numbness, tingling or a heavy pulling sensation from nerve irritation, pigment change inside the treated field, and visible asymmetry between the two sides while everything settles. Rarely, a fat pad beneath a treated area loses a little of its volume, and that is the specific risk a director weighs on a thin face.
Where the weighting differs is in what compensates for the risk. Prime confirms depth on a monitor before each line, which is the argument for using it over bone, near the orbital rim or on a face whose layers are unusually thin. Shurink is aimed from examination and cartridge choice, so the pre-treatment assessment is carrying more of the load, and a rushed examination is a poor trade on either platform.
Your history is what shortens the list. Declare medication and supplements, any bleeding tendency, filler, threads or previous energy work in the same field, implanted electrical devices, metal in the treatment area, and any record of keloid scarring or pigment trouble. Afterwards, contact the clinic promptly if pain climbs after the first days, if redness spreads outward, if a numb patch shows no sign of receding, or if one side of the face begins to move differently from the other. A medical director is on site through clinic hours, so a worried patient is examined in person.